The Future of Pharma – Looking Ahead to 2026
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Future of pharma report: explore drug development trends, regulatory shifts, clinical pipelines, and market opportunities shaping the biopharmaceutical industry.
Understand Where the Pharmaceutical Industry Is Heading
The pharmaceutical industry is entering a phase of rapid transformation, driven by shifts in drug development, regulation, and market dynamics.
This report provides a clear, high-level view of both near-term and long-term changes shaping the industry, helping you understand how these shifts impact strategy, investment, and innovation.
It brings together regulatory, clinical, and market-based analysis to highlight the major forces influencing the future of pharma.
Report Value Proposition – Why This Matters for You
This report helps you cut through complexity and focus on what actually matters.
You can use it to:
- Identify emerging trends shaping drug development
- Track regulatory and clinical shifts impacting pipelines
- Spot near-term opportunities and potential risks
- Align investment and business development strategies
- Understand which companies and areas are gaining momentum
Key Insights in the Future of Pharma
The industry is being shaped by a combination of regulatory developments, clinical pipeline evolution, and shifting market dynamics.
Short-term changes in 2026 are expected to influence both opportunities and risks, while longer-term trends will define how the market evolves over the next five years.
Clinical activity continues to play a central role, with ongoing and planned trials offering insight into where innovation is heading.
At the same time, sales forecasts and pipeline analysis provide a forward-looking view of future growth areas.

Scope
What You Will Learn
A forward-looking view of the pharmaceutical industry, including:
- Key trends shaping drug development
- Regulatory and clinical shifts influencing the market
- Opportunities and threats expected in 2026
- Long-term opportunities projected over the next five years
- Clinical trial activity and pipeline developments
Target Buyers for This Report
This report is designed for decision-makers across the pharmaceutical ecosystem:
- Pharma and biotech companies
- Business development and investment teams
- Strategy and market intelligence professionals
- Investors and advisors
How Companies Use This Report
- Pharmaceutical companies
Align portfolios with future drug development trends - Business development teams
Identify partnership and investment opportunities - Investors and analysts
Evaluate companies and emerging growth areas - Strategy and market intelligence teams
Track industry shifts and competitive positioning
Reasons to Buy
Benchmark Trends, Pipelines and Market Shifts
The report provides a structured view of key industry movements:
- Regulatory and Market Analysis
Understand how regulatory changes and market conditions are shaping the industry. - Clinical Pipeline Insights
Track ongoing and planned clinical trials and their impact on future development. - Sales Forecasts
Explore projections that highlight future opportunities and risks. - Company Positioning
Identify which companies are expected to lead in the near and long term.
Built on Trusted Data and Expert Analysis
This report combines multiple layers of insight to deliver a clear industry outlook.
- Includes regulatory, clinical, and market-based analysis
- Supported by sales forecasts and pipeline data
- Features 28 figures illustrating key trends and projections
Act Now to Stay Ahead of Pharma Transformation
The future of pharma is being shaped now through clinical innovation, regulatory shifts, and evolving market dynamics.
This report gives you the clarity to identify opportunities, manage risks, and position your strategy for what’s next.
If you are planning investments, partnerships, or portfolio strategy, this is where you gain direction.
Bristol-Myers Squibb Co
AstraZeneca Plc
Novartis AG
F. Hoffmann-La Roche Ltd
Merck & Co Inc
Johnson & Johnson
Sanofi
Pfizer Inc
AbbVie Inc
Eli Lilly and Co
Biogen Inc
UCB Pharma
Otsuka Pharmaceutical Co Ltd
Amgen Inc
Merck KGaA
Novo Nordisk AS
Regeneron Pharmaceuticals Inc
Genentech
Gilead Sciences
AddPharma
Avidity Biosciences Inc
Bio-Thera Solutions Inc
Boehringer Ingelheim
Concept Therapeutics
CSPC Pharmaceutical Group Ltd
InSilico Medicine
Jiangsu Hengrui Pharmaceuticals Co Ltd
MannKind Corp
Orca Biosystems
Revolution Medicines Inc
Structure Therapeutics Inc
Summit Therapeutics Inc
Travere Therapeutics Inc
Vanda Pharmaceuticals Inc
Table of Contents
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Pharmaceuticals reports
